These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36989302)

  • 1. HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E.
    Cosper PF; Hrycyniak LCF; Paracha M; Lee DL; Wan J; Jones K; Bice SA; Nickel K; Mallick S; Taylor AM; Kimple RJ; Lambert PF; Weaver BA
    Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2216700120. PubMed ID: 36989302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
    Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
    Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial Species from Vaginal Microbiota Differently Affect the Production of the E6 and E7 Oncoproteins and of p53 and p-Rb Oncosuppressors in HPV16-Infected Cells.
    Nicolò S; Antonelli A; Tanturli M; Baccani I; Bonaiuto C; Castronovo G; Rossolini GM; Mattiuz G; Torcia MG
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    Vats A; Trejo-Cerro O; Massimi P; Banks L
    J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
    Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
    PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
    Ben Khalifa Y; Teissier S; Tan MK; Phan QT; Daynac M; Wong WQ; Thierry F
    PLoS Pathog; 2011 Sep; 7(9):e1002256. PubMed ID: 21980285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
    Drews CM; Case S; Vande Pol SB
    PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.
    Cornet I; Bouvard V; Campo MS; Thomas M; Banks L; Gissmann L; Lamartine J; Sylla BS; Accardi R; Tommasino M
    J Virol; 2012 Feb; 86(4):2366-70. PubMed ID: 22171257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.